DSM Pharmaceutical Products forms manufacturing alliance with Galenix
US-based DSM Pharmaceutical Products has made a manufacturing alliance with Galenix, of Saint Jean D'Illac, France, whereby DSM will be the preferred commercial-scale manufacturing partner for Galenix commercial products on a global basis. No financial terms were disclosed.
US-based DSM Pharmaceutical Products has made a manufacturing alliance with Galenix, of Saint Jean D'Illac, France, whereby DSM will be the preferred commercial-scale manufacturing partner for Galenix commercial products on a global basis. No financial terms were disclosed.
The two companies will collaborate on business development opportunities co-marketing Galenix drug delivery technologies, based on the strength of Galenix in drug product development and clinical services and DSM in process development, scale-up and commercial-scale pharmaceutical manufacturing.
"These innovative drug delivery technologies enhance our offering in the field of pharmaceutical development services and complement our portfolio of drug delivery technologies," said Pieter de Geus, DSM Senior Vice President, r&d.
Jerome Besse, ceo of Galenix, concurred, adding: "The partnership fits with our strategic intention of expanding service offerings to the North America market, and also with DSM's expansion of sales & marketing focus in Europe."
